CING Cingulate Inc
Company Analysis
Latest News
🟢 Cingulate is trading 5% up today as healthcare rises 2.12%
Cingulate is trading 5.28% higher at $4.59 on October 20, 2026, in a move more consistent with a broader healthcare-sector rally than a new company catalyst. -...
🟢 Cingulate is trading 15.6% up in pre-market
Cingulate is trading at $5.04, up 15.60%, in pre-market on October 20, 2026, with no clear company-specific announcement identified to explain the rise. -...
🔴 Cingulate is trading 5% down — no verified company-specific catalyst
Cingulate is trading 5.47% lower at $4.32, with no verified company-specific announcement explaining the October 15, 2026 decline. - Broader risk-off...
🟢 Cingulate is trading 5.8% up in after-hours trading — catalyst remains unclear
Cingulate is trading 5.8% up at $4.83 after hours, with no verified company-specific announcement explaining the move. - This compares with the October 14...
🟢 Cingulate is trading 11.3% up in pre-market; catalyst remains unclear
Cingulate is trading at $5.39, up 11.31% in pre-market, with no identified company-specific catalyst. - The company’s official press-release page lists...
🔴 Cingulate is trading 5.7% down in pre-market; catalyst remains unclear
Cingulate is trading 5.7% lower at $4.61, with no corroborated catalyst for the October 12 pre-market decline. - The stock closed at $4.89 on October 9. - The...
🔴 Cingulate is trading 5% down in pre-market
Cingulate is trading at $4.70, down 5.05% in pre-market, with no clear catalyst identified. - No company announcement dated September 30 or October 1 appears...
🟢 Cingulate is trading 5% up in pre-market with no clear catalyst
Cingulate is trading 5.31% up at $5.09 in pre-market on September 28, with no clear company-specific catalyst identified in available reports. - The latest...